Inovio Pharmaceuticals Inc vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $17.67. The key difference: Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | PDBC | |
|---|---|---|
Market Cap | $89.27M | — |
Sector | Health | — |
52-Week High | $2.87 | $18.91 |
52-Week Low | $1.05 | $12.90 |
Enterprise Value | $60.28M | — |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →